MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with Parkinson’s disease: a meta-analysis of randomized controlled trials

P. He, L. Wang, J. Chen, Y. Zhang, Y. Gao, Q. Xu, Y. Qiu, H. Cai, Y. Li, Z. Huang, S. Feng, J. Zhao, G. Ma, K. Nie, L. Wang (Guangzhou, China)

Meeting: MDS Virtual Congress 2020

Abstract Number: 401

Keywords: Cognitive dysfunction, Parkin, Repetitive transcranial magnetic stimulation(rTMS)

Category: Parkinson's Disease: Cognitive functions

Objective: This study aimed to evaluate the effects of rTMS for improving cognition of PD patients.

Background: Up to 20%–50% of patients with Parkinson’s disease (PD) have cognitive impairment. Repetitive transcranial magnetic stimulation (rTMS) is a nonpharmacological treatment option for cognitive impairment in PD while its curative effect is unclear.

Method: Four online databases (PubMed, Cochrane Library, EMBase, Web of Science) were extensively searched from their inception through December 2018. Randomized controlled trials were included if they examined the impact of rTMS on cognition.

Results: Seven studies met the inclusions criteria. The quality of evidence in these studies was rated as moderate to high. Compared with sham-controlled group, the pooled result showed a non-significant effect of rTMS on global cognition (post-intervention effect WMD:-0.42, 95% CI: -1.46 to 0.63; one-month follow-up result WMD: 0.11, 95% CI: –0.88 to 1.10), executive function (post-intervention effect SMD: 0.11, 95% CI: -0.17 to 0.40; one-month follow-up result SMD: 0.24, 95% CI: –0.11 to 0.58), as well as attention and working memory (post-intervention effect SMD:-0.17, 95% CI: -0.60 to 0.26; one-month follow-up result SMD: –0.0, 95% CI: –0.48 to 0.48). As regard to study design, neurological test, disease severity and stimulation parameter concerning simulating site, number of sessions as well as rTMS frequency, no effects were observed.

Conclusion: Based on limited studies, the effect of rTMS in PD seemed to be negative. We called for more high-quality randomized controlled trials with adequate sample sizes to demonstrate the actual effects of rTMS in the future.

To cite this abstract in AMA style:

P. He, L. Wang, J. Chen, Y. Zhang, Y. Gao, Q. Xu, Y. Qiu, H. Cai, Y. Li, Z. Huang, S. Feng, J. Zhao, G. Ma, K. Nie, L. Wang. Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with Parkinson’s disease: a meta-analysis of randomized controlled trials [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/repetitive-transcranial-magnetic-stimulation-rtms-fails-to-improve-cognition-in-patients-with-parkinsons-disease-a-meta-analysis-of-randomized-controlled-trials/. Accessed November 15, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/repetitive-transcranial-magnetic-stimulation-rtms-fails-to-improve-cognition-in-patients-with-parkinsons-disease-a-meta-analysis-of-randomized-controlled-trials/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley